# XENLETA
> **NDA211673** · New Drug Application · Sponsor: HONG KONG · Approved 2019-08-19
## Drug
- **FDA Application Number:** NDA211673
- **Application type:** New Drug Application
- **Brand name:** XENLETA
- **Generic name:** Lefamulin Acetate
- **Active ingredients:** LEFAMULIN ACETATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HONG KONG
- **First approval:** 2019-08-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211673)
---
*AI Analytics · CC0 1.0*